Retinal signs and stroke: Revisiting the link between the eye and brain

Stroke

Volumn 39, Issue 4, 2008, Pages 1371-1379

  Baker, Michelle L ^a,b   Hand, Peter J ^b   Wang, Jie Jin ^a,c   Wong, Tien Y ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Diabetic retinopathy; Hypertensive retinopathy; Mortality; Population based cohort; Stroke

Indexed keywords

ARTERIOLE; BLOOD PRESSURE; BRAIN INFARCTION; CARDIOVASCULAR RISK; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERTENSION RETINOPATHY; INCIDENCE; MICROANEURYSM; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA BLOOD VESSEL; RETINA EXAMINATION; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RETINA VEIN OCCLUSION; REVIEW; RISK FACTOR; STROKE;

HUMANS; RETINAL DISEASES; RISK FACTORS; STROKE;

EID: 41149145777     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.496091     Document Type: Review

References (90)

1. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JN, Bull LM, Welch SJ, Cuthbertson FC, Binney LE, Gutnikov SA, Anslow P, Banning AP, Mant D, Mehta Z. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (oxford vascular study). Lancet. 2005;366:1773-1783.
2. Varona JF, Guerra JM, Bermejo F, Molina JA, Gomez de la Camara A. Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term. Eur Neurol. 2007;57:212-218.
3. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology. 1982;89:1132-1145.
4. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: A rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005;206:319-348.
5. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, Wofford MR, Sharrett AR. Retinal microvascular abnormalities and incident stroke: The atherosclerosis risk in communities study. Lancet. 2001;358:1134-1140.
6. Wong TY, Klein R, Sharrett AR, Manolio TA, Hubbard LD, Marino EK, Kuller L, Burke G, Tracy RP, Polak JF, Gottdiener JS, Siscovick DS. The prevalence and risk factors of retinal microvascular abnormalities in older persons: The cardiovascular health study. Ophthalmology. 2003;110:658-666.
7. Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR, Meuer SM, Hubbard LD, Tielsch JM. Retinal microvascular abnormalities and 10-year cardiovascular mortality: A population-based case-control study. Ophthalmology. 2003;110:933-940.
8. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology. 2005;65:1005-1009.
9. Dozono K, Ishii N, Nishihara Y, Horie A. An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis. Stroke. 1991;22:993-996.
10. Hamada Y. [ophthalmological study of the m-strain stroke-prone spontaneously hypertensive rats (2). Retinal arteriolar changes in fluorescein angiogram]. Nippon Ganka Gakkai Zasshi. 1993;97:690-697.
11. Gunn RM. Opthalmocsopic evidence of (1) arterial changes associated with chronic renal diseases and (2) of increased arterial tension. Trans Ophthalmol Soc UK. 1892;12:124-125.
12. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: Their course and prognosis. Am J Med Sci. 1939;197:332-343.
13. Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol. 2001;46:59-80.
14. Dodson PM, Lip GY, Eames SM, Gibson JM, Beevers DG. Hypertensive retinopathy: A review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens. 1996;10:93-98.
15. Hayreh SS. Classification of hypertensive fundus changes and their order of appearance. Ophthalmologica. 1989;198:247-260.
16. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. Arch Ophthalmol. 1953;49:117-138.
17. Walsh JB. Hypertensive retinopathy. Description, classification, and prognosis. Ophthalmology. 1982;89:1127-1131.
18. Lin DY. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: A comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002;134:261-263.
19. Couper DJ, Klein R, Hubbard LD, Wong TY, Sorlie PD, Cooper LS, Brothers RJ, Nieto FJ. Reliability of retinal photography in the assessment of retinal microvascular characteristics: The atherosclerosis risk in communities study. Am J Ophthalmol. 2002;133:78-88.
20. Kaushik S, Tan AG, Mitchell P, Wang JJ. Prevalence and associations of enhanced retinal arteriolar light reflex: A new look at an old sign. Ophthalmology. 2007;114:113-120.
21. Sherry LM, Wang JJ, Rochtchina E, Wong T, Klein R, Hubbard L, Mitchell P. Reliability of computer-assisted retinal vessel measurement in a population. Clin Experiment Ophthalmol. 2002;30:179-182.
22. Wong TY, Klein R, Sun C, Mitchell P, Couper DJ, Lai H, Hubbard LD, Sharrett AR. Age-related macular degeneration and risk for stroke. Ann Intern Med. 2006;145:98-106.
23. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351:2310-2317.
24. Klein R, Klein BE, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature: The beaver dam eye study. Trans Am Ophthalmol Soc. 1997;95:329 -348; discussion 348-350.
25. Cugati S, Cikamatana L, Wang JJ, Kifley A, Liew G, Mitchell P. Five-year incidence and progression of vascular retinopathy in persons without diabetes: The blue mountains eye study. Eye. 2006;20:1239-1245.
26. Dimmitt SB, West JN, Eames SM, Gibson JM, Gosling P, Littler WA. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet. 1989;1:1103-1106.
27. Wise GN, Dollery CT, Henkind P. The Retinal Circulation. New York: Harper and Row; 1971.
28. Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD, Couper DJ, Heiss G, Sorlie PD. Retinal microvascular abnormalities and mri-defined subclinical cerebral infarction: The atherosclerosis risk in communities study. Stroke. 2006;37:82-86.
29. Longstreth W Jr, Larsen EK, Klein R, Wong TY, Sharrett AR, Lefkowitz D, Manolio TA. Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: The cardiovascular health study. Am J Epidemiol. 2007;165:78-84.
30. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112:92-98.
31. Wong T, Mitchell P. The eye in hypertension. Lancet. 2007;369:425-435.
32. Newsom RS, Sullivan PM, Rassam SM, Jagoe R, Kohner EM. Retinal vessel measurement: Comparison between observer and computer driven methods. Graefes Arch Clin Exp Ophthalmol. 1992;230:221-225.
33. Suzuki Y. Direct measurement of retinal vessel diameter: Comparison with microdensitometric methods based on fundus photographs. Surv Ophthalmol. 1995;39 Suppl 1:S57-65.
34. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: A review. Stroke. 1997;28:652-659.
35. Klijn CJ, Kappelle LJ, van Schooneveld MJ, Hoppenreijs VP, Algra A, Tulleken CA, van Gijn J. Venous stasis retinopathy in symptomatic carotid artery occlusion: Prevalence, cause, and outcome. Stroke. 2002;33:695-701.
36. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci. 2003;44:4644-4650.
37. Ikram MK, de Jong FJ, Bos MJ, Vingerling JR, Hofman A, Koudstaal PJ, de Jong PT, Breteler MM. Retinal vessel diameters and risk of stroke: The rotterdam study. Neurology. 2006;66:1339-1343.
38. Parr JC, Spears GF. General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery. Am J Ophthalmol. 1974;77:472-477.
39. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR, Davis MD, Cai J. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study. Ophthalmology. 1999;106:2269-2280.
40. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res. 2003;27:143-149.
41. Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, Evans G. Are retinal arteriolar abnormalities related to atherosclerosis?: The atherosclerosis risk in communities study. Arterioscler Thromb Vasc Biol. 2000;20:1644-1650.
42. Ikram MK, de Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM, de Jong PT. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The rotterdam study. Invest Ophthalmol Vis Sci. 2004;45:2129-2134.
43. Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM, De Jong PT. Retinal vessel diameters and cerebral small vessel disease: The rotterdam scan study. Brain. 2006;129:182-188.
44. Wong TY, Kamineni A, Klein R, Sharrett AR, Klein BE, Siscovick DS, Cushman M, Duncan BB. Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: The cardiovascular health study. Arch Intern Med. 2006;166:2388-2394.
45. Wang JJ, Liew G, Klein R, Rochtchina E, Knudtson MD, Klein BE, Wong TY, Burlutsky G, Mitchell P. Retinal vessel diameter and cardiovascular mortality: Pooled data analysis from two older populations. Eur Heart J. 2007.
46. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF. The prevalence of diabetic retinopathy among adults in the united states. Arch Ophthalmol. 2004;122:552-563.
47. Wong TY, Klein R, Amirul Islam FM, Cotch MF, Couper DJ, Klein BE, Hubbard LD, Sharrett AR. Three-year incidence and cumulative prevalence of retinopathy: The atherosclerosis risk in communities study. Am J Ophthalmol. 2007;143:970-976.
48. Davis TM, Millns H, Stratton IM, Holman RR, Turner RC. Risk factors for stroke in type 2 diabetes mellitus: United kingdom prospective diabetes study (ukpds) 29. Arch Intern Med. 1999;159:1097-1103.
49. Petitti DB, Bhatt H. Retinopathy as a risk factor for nonembolic stroke in diabetic subjects. Stroke. 1995;26:593-596.
50. Iino K, Yoshinari M, Kaku K, Yamamoto M, Sato Y, Kodama T, Iwase M, Fujishima M. Prospective study of asymmetric retinopathy as a predictor of brain infarction in diabetes mellitus. Diabetes Care. 1993;16:1405-1406.
51. Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, Wong TY, Brancati FL, Hubbard LD, Couper D. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : The atherosclerosis risk in communities study. Ophthalmology. 2002;109:1225-1234.
52. Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, Wong TY. Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke. 2007;38:398-401.
53. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15:1875-1891.
54. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117:1487-1495.
55. O'Donnell BA, Mitchell P. The clinical features and associations of retinal emboli. Aust N Z J Ophthalmol. 1992;20:11-17.
56. Klein R, Klein BE, Jensen SC, Moss SE, Meuer SM. Retinal emboli and stroke: The beaver dam eye study. Arch Ophthalmol. 1999;117:1063-1068.
57. Mitchell P, Wang JJ, Li W, Leeder SR, Smith W. Prevalence of asymptomatic retinal emboli in an australian urban community. Stroke. 1997;28:63-66.
58. Wong TY, Klein R. Retinal arteriolar emboli: Epidemiology and risk of stroke. Curr Opin Ophthalmol. 2002;13:142-146.
59. Wang JJ, Cugati S, Knudtson MD, Rochtchina E, Klein R, Klein BE, Wong TY, Mitchell P. Retinal arteriolar emboli and long-term mortality: Pooled data analysis from two older populations. Stroke. 2006;37:1833-1836.
60. Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE, Hubbard LD, Siscovick DS, Sharrett AR. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: The atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology. 2005;112:540-547.
61. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal emboli in an older population. Stroke. 2006;37:908-910.
62. Klein R, Klein BE, Jensen SC, Moss SE, Meuer SM. Retinal emboli and stroke: The beaver dam eye study. Arch Ophthalmol. 1999;117.
63. Klein R, Klein BE, Moss SE, Meuer SM. Retinal emboli and cardiovascular disease: The beaver dam eye study. Arch Ophthalmol. 2003;121:1446-1451.
64. Mitchell P, Wang JJ, Smith W. Risk factors and significance of finding asymptomatic retinal emboli. Clin Experiment Ophthalmol. 2000;28:13-17.
65. Chua B, Kifley A, Wong TY, Mitchell P. Homocysteine and retinal vein occlusion: A population-based study. Am J Ophthalmol. 2005;139:181-182.
66. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005;24:493-519.
67. Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N. Retinal vascular occlusion and deficiencies in the protein c pathway. Am J Ophthalmol. 1999;128:69-74.
68. Gottlieb JL, Blice JP, Mestichelli B, Konkle BA, Benson WE. Activated protein c resistance, factor v leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol. 1998;116:577-579.
69. Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost. 2001;86:772-776.
70. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in australia. The blue mountains eye study. Arch Ophthalmol. 1996;114:1243-1247.
71. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: The beaver dam eye study. Trans Am Ophthalmol Soc. 2000;98:133-141; discussion 141-133.
72. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: The blue mountains eye study. Arch Ophthalmol. 2006;124:726-732.
73. Cugati S, Wang JJ, Knudtson MD, Rochtchina E, Klein R, Klein BE, Wong TY, Mitchell P. Retinal vein occlusion and vascular mortality: Pooled data analysis of 2 population-based cohorts. Ophthalmology. 2007;114:520-524.
74. Ueda Y, Kanazawa S, Ohira A, Miyamura N, Takaki T, Kitaoka T, Amemiya T. Retinal vascular obstruction and asymptomatic cerebral infarction. Jpn J Ophthalmol. 2002;46:209-214.
75. Tsaloumas MD, Kirwan J, Vinall H, O'Leary MB, Prior P, Kritzinger EE, Dodson PM. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye. 2000;14:821-827.
76. Mansour AM, Walsh JB, Henkind P. Mortality and morbidity in patients with central retinal vein occlusion. Ophthalmologica. 1992;204:199-203.
77. Rubinstein K, Jones EB. Retinal vein occlusion: Long-term prospects: 10 years' follow-up of 143 patients. Br J Ophthalmol. 1976;60:148-150.
78. Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology. 1990;97:1543-1548.
79. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in australia. The blue mountains eye study. Ophthalmology. 1995;102:1450-1460.
80. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The beaver dam eye study. Ophthalmology. 1992;99:933-943.
81. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT. The prevalence of age-related maculopathy in the rotterdam study. Ophthalmology. 1995;102:205-210.
82. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: The beaver dam eye study. Ophthalmology. 2007;114:253-262.
83. Klein R, Klein BE, Marino EK, Kuller LH, Furberg C, Burke GL, Hubbard LD. Early age-related maculopathy in the cardiovascular health study. Ophthalmology. 2003;110:25-33.
84. Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BE, King WN, Folsom AR. Prevalence of age-related maculopathy in the atherosclerosis risk in communities study. Arch Ophthalmol. 1999;117:1203-1210.
85. Hyman LG, Lilienfeld AM, Ferris FL III, Fine SL. Senile macular degeneration: A case-control study. Am J Epidemiol. 1983;118:213-227.
86. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial united states population: The national health and nutrition examination survey iii. Ophthalmology. 1999;106:1056-1065.
87. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH. Cerebral white matter lesions, retinopathy, and incident clinical stroke. Jama. 2002;288:67-74.
88. Bruno A, Russell PW, Jones WL, Austin JK, Weinstein ES, Steel SR. Concomitants of asymptomatic retinal cholesterol emboli. Stroke. 1992;23:900-902.
89. Sabbatini M, Tomassoni D, Di Tullio MA, Amenta F. Neuroprotective effect of treatment with calcium antagonists on hypertensive retina. Clin Exp Hypertens. 2002;24:727-740.
90. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertension. 1984;6:III158-III162.